Bone morphogenetic proteins secreted by breast cancer cells upregulate bone sialoprotein expression in preosteoblast cells

Experimental Cell Research

Volumn 260, Issue 2, 2000, Pages 324-333

  Bunyaratavej, Pintippa ^a,b   Hullinger, Thomas G ^c   Somerman, Martha J ^a,d  

^a UNIVERSITY OF MICHIGAN SCHOOL OF DENTISTRY   (United States)

^b CHIANG MAI UNIVERSITY   (Thailand)

^c PFIZER INC   (United States)

^d UNIVERSITY OF MICHIGAN SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Bone morphogenetic proteins; Bone sialoprotein; Breast cancer; Osteoblasts

Indexed keywords

BONE MORPHOGENETIC PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; MITOGEN ACTIVATED PROTEIN KINASE KINASE; SIALOPROTEIN;

ARTICLE; BONE METABOLISM; BONE METASTASIS; BREAST CARCINOMA; CANCER CELL; CARCINOGENESIS; CELL ACTIVITY; CELL FUNCTION; CELL LINE; CELL PROLIFERATION; CONTROLLED STUDY; COULTER COUNTER; GENE EXPRESSION; GENE TARGETING; HUMAN; HUMAN CELL; MINERALIZATION; NORTHERN BLOTTING; OSTEOBLAST; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; SIGNAL TRANSDUCTION; STEM CELL;

EID: 0034332551     PISSN: 00144827     EISSN: None     Source Type: Journal    
DOI: 10.1006/excr.2000.5019     Document Type: Article

References (73)

1. The nature of metastatic bone disease
2. Scanning electron microscopy in bone pathology: Review of methods, potential and applications
3. Breast carcinomas synthesize factors which influence osteoblast-like cells independently of osteoclasts in vitro
4. Secretory products of breast cancer cells specifically affect human osteoblastic cells: Partial characterization of active factors
5. Breast cancer cells interact with osteoblasts to support osteoclast formation
6. Cellular and molecular regulation of bone turnover
7. Regulation of osteoclast activity
8. Osteoblasts/stromal cells stimulate osteoclast activation through expression of osteoclast differentiation factor/RANKL but not macrophage colony-stimulating factor: Receptor activator of NF-kappa B ligand
9. Expression of bone morphogenetic protein messenger RNAs by normal rat and human prostate and prostate cancer cells
10. Bone morphogenetic protein-6 expression in normal and malignant prostate
11. Immunolocalization and messenger RNA expression of bone morphogenetic protein-6 in human benign and malignant prostatic tissue
12. Identification of bone morphogenetic proteins and their receptors in human breast cancer cell lines: Importance of bmp2
13. Bone morphogenetic protein 2 (BMP-2) enhances BMP-3, BMP-4, and bone cell differentiation marker gene expression during the induction of mineralized bone matrix formation in cultures of fetal rat calvarial osteoblasts
14. Bone morphogenetic proteins induce the expression of noggin, which limits their activity in cultured rat osteoblasts
15. The effects of estrogens and antiestrogens on hormone-responsive human breast cancer in long-term tissue culture
16. Secretory products from PC-3 and MCF-7 tumor cell lines upregulate osteopontin in MC3T3-E1 cells
17. Distinct proliferative and differentiated stages of murine MC3T3-E1 cells in culture: An in vitro model of osteoblast development
18. Effects of ascorbic acid on collagen matrix formation and osteoblast differentiation in murine MC3T3-E1 cells
19. Rapid, small-scale RNA isolation from tissue culture cells
20. cDNA cloning, mRNA distribution and heterogeneity, chromosomal location, and RFLP analysis of human osteopontin (OPN)
21. Murine bone sialoprotein (BSP): cDNA cloning, mRNA expression, and genetic mapping
22. Isolation of the human gene for bone gla protein utilizing mouse and rat cDNA clones
23. Cloning and sequencing of a deoxyribonucleic acid copy of glyceraldehyde-3-phosphate dehydrogenase messenger ribonucleic acid isolated from chicken muscle
24. Ribosomal DNA of the fly Sciara comprophila has a very small and homogenous repeat unit
25. Identification of a bone matrix-derived chemotactic factor
26. Expression of bone morphogenetic protein 6 in normal mammary tissue and breast cancer cell lines and its regulation by epidermal growth factor
27. Bone morphogenetic protein-2 stimulates alkaline phosphatase activity and collagen synthesis in cultured osteoblastic cells, MC3T3-E1
28. Human osteogenic protein-1 induces chondroblastic, osteoblastic, and/or adipocytic differentiation of clonal murine target cells
29. The Spemann organizer signal noggin binds and inactivates bone morphogenetic protein 4
30. Noggin, cartilage morphogenesis, and joint formation in the mammalian skeleton
31. Bone sialoprotein
32. Nucleation of hydroxyapatite by bone sialoprotein
33. Reaction of bone to metastasis from carcinoma of the breast and the prostate
34. Stimulation by bone sialoprotein of calcification in osteoblast-like MC3T3-E1 cells
35. Osteoblast and chondroblast differentiation
36. Regulation of bone matrix protein expression and induction of differentiation of human osteoblasts and human bone marrow stromal cells by bone morphogenetic protein-2
37. Osteopontin overview
38. Attachment of osteoblastic cells to hydroxyapatite crystals by a synthetic peptide (Glu7-Pro-Arg-Gly-Asp-Thr) containing two functional sequences of bone sialoprotein
39. Expression of bone sialoprotein (BSP) in developing human tissues
40. Detection of bone sialoprotein in human breast cancer tissue and cell lines at both protein and messenger ribonucleic acid levels
41. Bone sialoprotein expression in primary human breast cancer is associated with bone metastases development
42. Expression of bone matrix proteins in human breast cancer: Potential roles in microcalcification formation and in the genesis of bone metastases
43. Ultrastructural immunodetection of osteopontin and osteocalcin as major matrix components of renal calculi
44. Immunohistochemical localization of bone sialoprotein in foetal porcine bone tissues: Comparisons with secreted phosphoprotein 1 (SPP-1, osteopontin) and SPARC (osteonectin)
45. Human bone sialoprotein I and II enhance fibroblast attachment in vitro
46. Rat osteoclasts adhere to a wide range of RGD (Arg-Gly-Asp) peptide-containing proteins, including the bone sialoproteins and fibronectin, via a beta 3 integrin
47. RGD-directed attachment of isolated rat osteoclasts to osteopontin, bone sialoprotein, and fibronectin
48. Bone sialoprotein supports breast cancer cell adhesion proliferation and migration through differential usage of the alpha(v)beta3 and alpha(v)beta5 integrins
49. Localization of bone sialoprotein (BSP) expression to sites of mineralized tissue formation in fetal rat tissues by in situ hybridization
50. Bone sialoprotein mRNA expression and ultrastructural localization in fetal porcine calvarial bone: Comparisons with osteopontin
51. Transcription of the bone sialoprotein gene is stimulated by v-Src acting through an inverted CCAAT box
52. Characteristics of vitamin D3 receptor (VDR) binding to the vitamin D response element (VDRE) in rat bone sialoprotein gene promoter
53. Role of two mineral-associated adhesion molecules, osteopontin and bone sialoprotein, during cementogenesis
54. Glucocorticoid regulation of bone sialoprotein (BSP) gene expression. Identification of a glucocorticoid response element in the bone sialoprotein gene promoter
55. Transforming growth factor-beta 1 regulation of bone sialoprotein gene transcription: Identification of a TGF-beta activation element in the rat BSP gene promoter
56. Regulation of bone sialoprotein mRNA by steroid hormones
57. Bone sialoprotein stimulates in vitro bone resorption
58. Elucidating the functions of bone sialoprotein and osteopontin in bone formation
59. Signal transduction pathways mediating parathyroid hormone stimulation of bone sialoprotein gene expression in osteoblasts
60. Expression of bone matrix proteins associated with mineralized tissue formation by adult rat bone marrow cells in vitro: Inductive effects of dexamethasone on the osteoblastic phenotype
61. Induction of rapid osteoblast differentiation in rat bone marrow stromal cell cultures by dexamethasone and BMP-2
62. The role of TFG-b and BMP-7 in regenerating bone and soft tissues
63. Stimulatory effect of bone morphogenetic protein-2 on osteoclast-like cell formation and bone-resorbing activity
64. Opposing BMP and EGF signalling pathways converge on the TGF-beta family mediator Smad1
65. Genetic characterization and cloning of mothers against dpp, a gene required for decapentaplegic function in Drosophila melanogaster
66. Intracellular signalling: The mad way to do it
67. TGFbeta signaling: Receptors, transducers, and Mad proteins
68. Signal transduction by bone morphogenetic proteins
69. The MAP kinase cascade is essential for diverse signal transduction pathways
70. Osteolytic bone metastases in breast carcinoma pathogenesis, morbidity and biphosphonate treatment
71. Transforming growth factor-beta and prostate cancer
72. TGF-beta signalling blockade inhibits PTHrP secretion by breast cancer cells and bone metastases development
73. Transforming growth factor beta1 acts as an inducer of matrix metalloproteinase expression and activity in human bone-metastasizing cancer cells